ClinicalTrials.Veeva

Menu
M

Medical University of Innsbruck | Neurology Clinic

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 425809
Nintedanib
Dabigatran Etexilate
Atezolizumab
Chemotherapy+Bevacizumab
Lucitanib
Candesartan
BI 685509
Ropivacaine
Rivaroxaban

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 85 total trials

[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake (NeoRay)

The purpose of this first-in-human (FIH) study of \[177Lu\]-NeoB is to characterize the safety, tolerability, pharmacokinetics (PK) as well as the di...

Enrolling
Neoplasms
Drug: [68Ga]-NeoB
Drug: LCZ696

A study to investigate bowel urgency in adults with moderately to severely active ulcerative colitis (UC) treated with mirikizumab. The study will ha...

Active, not recruiting
Ulcerative Colitis Chronic
Ulcerative Colitis
Drug: Mirikizumab

This study is open to adults with different types of advanced cancer (solid tumors) that are accessible for injection and/or biopsy. This is a study...

Enrolling
Solid Tumors
Drug: anti-PD-1 antibody
Drug: BI 1831169

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Enrolling
Obesity
Drug: Placebo
Drug: survodutide

This is a phase III, randomized, double-blinded, comparative, multi-centre study to assess the efficacy of atezolizumab in combination with platinum-...

Active, not recruiting
Ovarian Cancer
Drug: placebo + avastin + platinum-based chemotherapy
Drug: atezolizumab + avastin + platinum-based chemotherapy

Atezolizumab is an engineered humanised monoclonal immunoglobulin G1 antibody that binds selectively to PD-L1 and prevents its interaction with PD-1...

Active, not recruiting
Endometrial Cancer
Drug: Placebos
Drug: Atezolizumab

Early vascular aging has its origins in fetal and neonatal life. The NEOVASC clinical trial aims to determine the effects of an exclusive human milk...

Enrolling
Prematurity
Vascular Aging
Dietary Supplement: Humavant

The EPYGON VALVE is an innovative mitral valve, intended for valve replacement of a native mitral valve through a minimally invasive implant procedur...

Enrolling
Mitral Valve Regurgitation
Device: Epygon™ Transcatheter Mitral Valve System

This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and sy...

Enrolling
MSA - Multiple System Atrophy
Symptomatic Neurogenic Orthostatic Hypotension
Drug: Ampreloxetine
Drug: Placebo

The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderat...

Enrolling
Ulcerative Colitis
Drug: Tilpisertib Fosmecarbil
Drug: Placebo

Trial sponsors

M
Boehringer Ingelheim logo
Medical University of Vienna logo
M
Ipsen logo
A
A
I
A
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems